Zacks Company Profile for NanoString Technologies, Inc. (NSTG : NSDQ) |
|
|
|
Company Description |
NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.
Number of Employees: 766 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $16.01 |
Daily Weekly Monthly
 |
20 Day Moving Average: 1,055,550 shares |
Shares Outstanding: 46.42 (millions) |
Market Capitalization: $743.12 (millions) |
Beta: 1.98 |
52 Week High: $70.40 |
52 Week Low: $13.52 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-18.94% |
-8.71% |
12 Week |
-53.13% |
-48.48% |
Year To Date |
-62.09% |
-53.88% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
R. Bradley Gray - President; Chief Executive Officer
William D. Young - Chairman of the Board of Directors
K. Thomas Bailey - Chief Financial Officer
Elisha W. Finney - Director
Janet George - Director
|
|
Peer Information
NanoString Technologies, Inc. (BJCT)
NanoString Technologies, Inc. (CADMQ)
NanoString Technologies, Inc. (APNO)
NanoString Technologies, Inc. (UPDC)
NanoString Technologies, Inc. (IMTIQ)
NanoString Technologies, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 63009R109
SIC: 2836
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
|
|
Share - Related Items
Shares Outstanding: 46.42
Most Recent Split Date: (:1)
Beta: 1.98
Market Capitalization: $743.12 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.67 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-2.64 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 3.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/03/22 |
|
|
|
|